FDA Approved: TREXIMET — Supplemental Application (Currax Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for TREXIMET, the combination of sumatriptan succinate and naproxen sodium, by Currax Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• TREXIMET (sumatriptan succinate and naproxen sodium)

Snippet

SUPPL AP for TREXIMET (SUMATRIPTAN SUCCINATE AND NAPROXEN SODIUM)